Quest Diagnostics (DGX) To Buyback 15.4M Common from Glaxo (GSK) Affilate; Increases FY11 Outlook
Tweet Send to a Friend
Quest Diagnostics Incorporated (NYSE: DGX) announced that they have agreed to buyback 15.4 million common shares from their largest shareholder ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
